Forgot your password?
Haven't registered yet?
8/21/2015CMSC INforMS: Novartis acquires all remaining rights to GSK Ofatumumab to develop treatments for MS
8/3/2015CMSC INforMS: Pfizer & Synthon Enter Into U.S. Commercialization Agreement for Treatment of MS
7/28/2015CMSC INforMS: FDA: Gadolinium-based MRI Contrast Agents Pose Possible Brain Risk
9/3/2015 » 9/6/20152nd World Congress on NeuroTherapeutics (DDDN) Dilemmas, Debates, Discussions
9/25/2015 » 9/26/20155th International Symposium on Gait and Balance in Multiple Sclerosis: Fall Detection and Prevention